Memphasys is an ASX-listed reproductive biotechnology company driven by market needs to provide reproduction and fertility solutions for humans and animals alike
|
NEW ROLE: David Ali, Acting CEO, Executive Director | 01 Aug 2024 |
|
NEW ROLE: Robert Cooke, Non-Executive Chairman, Non-Executive Director | 01 Aug 2024 |
| NEW ROLE: Michael Atkins, Non-Executive Director | 01 Aug 2024 | |
|
NEW ROLE: David Ali, | 30 Oct 2023 |
|
NEW ROLE: Hassan Bakos, | 30 Oct 2023 |
|
NEWS: Tagged in Memphasys to reinvest tax refund in the next generation | 25 Oct 2023 |
|
NEWS: Tagged in Memphasys brings Indian baby dreams alive with Felix | 15 Sep 2023 |
|
NEWS: Tagged in Memphasys franks Japan deal with first Felix order | 14 Aug 2023 |
|
NEWS: Tagged in Memphasys inks deal with global IVF provider Vitrolife | 07 Aug 2023 |